Renovorx Inc (RNXT)

08:51 AM

RenovoRx CEO Shaun Bagai to Participate at the Canaccord Genuity MedTech, Diagnostics & Digital Health & Services Forum on November 20th - The Manila Times

08:51 AM

08:30 AM

RenovoRx (NASDAQ: RNXT) CEO Shaun Bagai to join Canaccord MedTech Forum on Nov 20 - Stock Titan

08:30 AM

07:08 AM

Is RenovoRx Inc. stock dividend yield sustainableFed Meeting & High Accuracy Swing Entry Alerts - newser.com

07:08 AM

Nov 03, 2025

Intraday pattern recognizer results for RenovoRx Inc.2025 Risk Factors & Weekly Watchlist for Consistent Profits - newser.com

Nov 03, 2025

Nov 03, 2025

Is RenovoRx Inc. stock supported by innovation pipeline2025 Sector Review & Proven Capital Preservation Methods - newser.com

Nov 03, 2025

Nov 03, 2025

Tick level data insight on RenovoRx Inc. volatilityWeekly Volume Report & Entry and Exit Point Strategies - newser.com

Nov 03, 2025

Nov 03, 2025

Can RenovoRx Inc. stock deliver consistent earnings growthTrade Entry Report & Short-Term Trading Opportunity Alerts - newser.com

Nov 03, 2025

Nov 03, 2025

Using AI based signals to follow RenovoRx Inc.2025 Sector Review & Safe Entry Point Alerts - newser.com

Nov 03, 2025

Nov 03, 2025

Is RenovoRx Inc. stock attractive for income investorsMarket Movers & Advanced Swing Trade Entry Plans - newser.com

Nov 03, 2025

Nov 03, 2025

Can machine learning forecast RenovoRx Inc. recoveryJuly 2025 Recap & Safe Capital Investment Plans - newser.com

Nov 03, 2025

Nov 03, 2025

Does RenovoRx Inc. fit your quant trading modelMarket Risk Report & Capital Efficiency Focused Ideas - newser.com

Nov 03, 2025

Nov 03, 2025

Will RenovoRx Inc. stock attract ESG investorsJuly 2025 WrapUp & Daily Profit Focused Stock Screening - newser.com

Nov 03, 2025

Nov 03, 2025

What analyst consensus says on RenovoRx Inc. stock2025 Pullback Review & Accurate Intraday Trading Signals - newser.com

Nov 03, 2025

Nov 02, 2025

Should I hold or sell RenovoRx Inc. stock in 20252025 Support & Resistance & Fast Entry Momentum Trade Alerts - newser.com

Nov 02, 2025

Nov 01, 2025

Why RenovoRx Inc. stock remains on watchlists2025 Dividend Review & Risk Managed Investment Strategies - newser.com

Nov 01, 2025

Oct 31, 2025

How to integrate RenovoRx Inc. into portfolio analysis toolsQuarterly Trade Review & Short-Term High Return Strategies - newser.com

Oct 31, 2025

Oct 31, 2025

Evaluating RenovoRx Inc. with trendline analysisJuly 2025 Short Interest & Long-Term Growth Plans - newser.com

Oct 31, 2025

Oct 29, 2025

First Patient Treated in RenovoCath Clinical Trial - Medical Product Outsourcing

Oct 29, 2025

Oct 27, 2025

RenovoRx’s PanTheR Registry Trial: A New Frontier in Tumor Treatment - TipRanks

Oct 27, 2025

Oct 27, 2025

RenovoRx’s Innovative Approach in Pancreatic Cancer Treatment: A Clinical Study Update - TipRanks

Oct 27, 2025

Oct 27, 2025

RenovoRx to Host Third Quarter 2025 Financial Results and Business Highlights Conference Call on November 13th at 4:30 p.m. ET - The Manila Times

Oct 27, 2025

Oct 27, 2025

RenovoRx (Nasdaq: RNXT) to host Q3 2025 call; RenovoCath and Phase III TIGeR-PaC - Stock Titan

Oct 27, 2025